Cargando…

Tumor Necrosis Factor Is a Therapeutic Target for Immunological Unbalance and Cardiac Abnormalities in Chronic Experimental Chagas' Heart Disease

Background. Chagas disease (CD) is characterized by parasite persistence and immunological unbalance favoring systemic inflammatory profile. Chronic chagasic cardiomyopathy, the main manifestation of CD, occurs in a TNF-enriched milieu and frequently progresses to heart failure. Aim of the Study. To...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pereira, Isabela Resende, Vilar-Pereira, Glaucia, Silva, Andrea Alice, Moreira, Otacilio Cruz, Britto, Constança, Sarmento, Ellen Diana Marinho, Lannes-Vieira, Joseli
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4130030/ https://www.ncbi.nlm.nih.gov/pubmed/25140115 http://dx.doi.org/10.1155/2014/798078

Ejemplares similares

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Severity of chronic experimental Chagas' heart disease parallels tumour necrosis factor and nitric oxide levels in the serum: models of mild and severe disease
por: Pereira, Isabela Resende, et al.
Publicado: (2014)

Memory impairment in chronic experimental Chagas disease: Benznidazole therapy reversed cognitive deficit in association with reduction of parasite load and oxidative stress in the nervous tissue
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2021)

Treatment With Suboptimal Dose of Benznidazole Mitigates Immune Response Molecular Pathways in Mice With Chronic Chagas Cardiomyopathy
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2021)

Behavioural alterations are independent of sickness behaviour in chronic experimental Chagas disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2015)

Treatment with benznidazole and pentoxifylline regulates microRNA transcriptomic profile in a murine model of Chagas chronic cardiomyopathy
por: Silva Grijó Farani, Priscila, et al.
Publicado: (2023)

Anxiety, depression, and memory loss in Chagas disease: a puzzle far beyond neuroinflammation to be unpicked and solved(*)
por: Lannes-Vieira, Joseli, et al.
Publicado: (2023)

Genetic Ablation and Pharmacological Blockade of Bradykinin B1 Receptor Unveiled a Detrimental Role for the Kinin System in Chagas Disease Cardiomyopathy
por: Oliveira, Ana Carolina, et al.
Publicado: (2023)

A Human Type 5 Adenovirus-Based Trypanosoma cruzi Therapeutic Vaccine Re-programs Immune Response and Reverses Chronic Cardiomyopathy
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Physical Exercise Promotes a Reduction in Cardiac Fibrosis in the Chronic Indeterminate Form of Experimental Chagas Disease
por: Pedra-Rezende, Yasmin, et al.
Publicado: (2021)

Priming astrocytes with TNF enhances their susceptibility to Trypanosoma cruzi infection and creates a self-sustaining inflammatory milieu
por: Silva, Andrea Alice, et al.
Publicado: (2017)

Multi-therapeutic strategy targeting parasite and inflammation-related alterations to improve prognosis of chronic Chagas cardiomyopathy: a hypothesis-based approach(*)
por: Lannes-Vieira, Joseli
Publicado: (2022)

Inducible Nitric Oxide Synthase in Heart Tissue and Nitric Oxide in Serum of Trypanosoma cruzi-Infected Rhesus Monkeys: Association with Heart Injury
por: Carvalho, Cristiano Marcelo Espinola, et al.
Publicado: (2012)

CCL3/Macrophage Inflammatory Protein-1α Is Dually Involved in Parasite Persistence and Induction of a TNF- and IFNγ-Enriched Inflammatory Milieu in Trypanosoma cruzi-Induced Chronic Cardiomyopathy
por: Gibaldi, Daniel, et al.
Publicado: (2020)

Single nucleotide polymorphisms of cytokine-related genes and association with clinical outcome in a Chagas disease case-control study from Brazil
por: Alvarado-Arnez, Lucia Elena, et al.
Publicado: (2018)

Resveratrol Reverses Functional Chagas Heart Disease in Mice
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

TGF-β inhibitor therapy decreases fibrosis and stimulates cardiac improvement in a pre-clinical study of chronic Chagas’ heart disease
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2019)

Monitoring the parasite load in chronic Chagas disease patients: comparison between blood culture and quantitative real time PCR
por: D’Ávila, Daniella Alchaar, et al.
Publicado: (2018)

Usefulness of real time PCR to quantify parasite load in serum samples from chronic Chagas disease patients
por: Melo, Myllena F, et al.
Publicado: (2015)

The Centennial of the Discovery of Chagas Disease: Facing the Current Challenges
por: Lannes-Vieira, Joseli, et al.
Publicado: (2010)

Trypanosoma cruzi activates mouse cardiac fibroblasts in vitro leading to fibroblast-myofibroblast transition and increase in expression of extracellular matrix proteins
por: Coelho, Laura Lacerda, et al.
Publicado: (2018)

Modulation of miR-145-5p and miR-146b-5p levels is linked to reduced parasite load in H9C2 Trypanosoma cruzi infected cardiomyoblasts
por: Farani, Priscila Silva Grijó, et al.
Publicado: (2022)

Revisiting Chagas' disease diagnostic strategies in light of different scenarios of Trypanosoma cruzi infection
por: Britto, Constança Carvalho
Publicado: (2022)

In Chagas disease, transforming growth factor beta neutralization reduces Trypanosoma cruzi infection and improves cardiac performance
por: Ferreira, Roberto Rodrigues, et al.
Publicado: (2022)

MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes
por: Navarro, Isabela Cunha, et al.
Publicado: (2015)

CD8(+) T-Cells Expressing Interferon Gamma or Perforin Play Antagonistic Roles in Heart Injury in Experimental Trypanosoma Cruzi-Elicited Cardiomyopathy
por: Silverio, Jaline Coutinho, et al.
Publicado: (2012)

Extracellular Vesicles: Potential Role in Remote Signaling and Inflammation in Trypanosoma cruzi-Triggered Disease
por: Dantas-Pereira, Luíza, et al.
Publicado: (2021)

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
por: Rodrigues-dos-Santos, Ícaro, et al.
Publicado: (2018)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil
por: Nielebock, Marco Antonio Prates, et al.
Publicado: (2020)

SYBR Green-based Real-Time PCR targeting kinetoplast DNA can be used to discriminate between the main etiologic agents of Brazilian cutaneous and visceral leishmaniases
por: Pita-Pereira, Daniela, et al.
Publicado: (2012)

Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection
por: Ferreira, Ludmila Rodrigues Pinto, et al.
Publicado: (2017)

Unbalance of intestinal microbiota in atopic children
por: Candela, Marco, et al.
Publicado: (2012)

Redox unbalance modifies neurogenic potential
por: Raciti, Marilena, et al.
Publicado: (2016)

Unbalance of Se and nutritional status in male infertility
por: da Cunha, Luana Mara Silva de Castro Pacheco, et al.
Publicado: (2021)

Unraveling Chagas disease transmission through the oral route: Gateways to Trypanosoma cruzi infection and target tissues
por: Silva-dos-Santos, Danielle, et al.
Publicado: (2017)

Genetic Polymorphism at CCL5 Is Associated With Protection in Chagas’ Heart Disease: Antagonistic Participation of CCR1(+) and CCR5(+) Cells in Chronic Chagasic Cardiomyopathy
por: Batista, Angelica Martins, et al.
Publicado: (2018)

Vascular Growth Factor Inhibition with Bevacizumab Improves Cardiac Electrical Alterations and Fibrosis in Experimental Acute Chagas Disease
por: Nisimura, Lindice Mitie, et al.
Publicado: (2023)

Experiments and Identification of the Unbalance of Aerostatic Guideways on the Micro-Scale
por: Chen, Dongju, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_24hm0kg3kvjm9mgbn2ss1ilk4o